To identify small‐molecule inhibitors that can suppress PD‐L1 expression, we performed cell‐based high‐content screening in non‐small‐cell lung cancer (NSCLC) cell line NCI‐H1299 and over 300 anti‐cancer drugs were evaluated in our screening (Table S1, Supporting Information). Here, CD274 is linked to cancer.